Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells
Down-regulation of S-phase kinase associated protein 2 (Skp2) induces apoptosis in oral cancer cells
复制标题
DOI:
10.1016/j.oraloncology.2005.02.007
复制
发表时间:
2005-07-01
期刊:
影响因子:
4.8
通讯作者:
Sato, M
中科院分区:
文献类型:
--
作者:
Harada, K;Supriatno;Sato, M
S-phase kinase associated protein 2 (Skp2) is a member of an F-box family of substrate-recognition subunits of SCF ubiquitin-protein ligase complexes that has been implicated in the ubiquitin-mediated degradation of several key regulators of mammalian G, progression, including the cyclin-dependent kinase inhibitor p27(Kip1), a dosage-dependent tumor suppressor protein. The anti-sense effect was confirmed in two cell lines of oral cancer cells that also exhibited over-expression of the Skp2 protein. In this study, we examined the mechanism responsible for anti-sense-mediated growth inhibition of oral cancer cells in vitro and in vivo. Skp2-anti-sense treatment induced apoptosis characterized by an increase in the early apoptosis, fragmentation of nuclei and activation of caspase-3, -8 and -9. Moreover, the growth of xenograft tumors was markedly suppressed by Skp2-antisense treatment. Furthermore, histological specimen revealed apoptotic cell death was increased in Skp2-anti-sense treated tumors. Our results suggest that down-regulation of Skp2 appears to induce apoptosis in oral cancer cells, targeting this molecule could represent a promising new therapeutic approach for this type of cancer. (c) 2005 Elsevier Ltd. All rights reserved.